HealthCare Global Enterprises Limited (HCG), an India-based cancer care provider, recently acquired the Mahatma Gandhi Cancer Hospital & Research Institute (MGCHRI) in Visakhapatnam (also known as Vizag) for Rs 414 crore (~$50 million). Veda Corporate Advisors, a mid-market investment bank, advised MGCHRI on the transaction.